Book Harvey Castro, MD, DR GPT™ for your board, leadership retreat, or healthcare AI event.
In a survey of 182 hospital leaders conducted in late 2025, only 29 percent had implemented and enforced policies covering AI model inventory, lineage, and sign-offs. Only 22 percent were highly confident they could produce a complete AI audit trail within 30 days if a regulator or payer asked (Becker's Hospital Review).
Meanwhile the oversight environment is firming up on a published schedule. The Joint Commission launched a voluntary Responsible Use of AI in Healthcare certification on June 2, 2026, and state statutes governing AI in clinical and payment decisions are taking effect through January 2027.
Your board does not need a technology briefing. It needs to know what the organization owns, who is accountable, how performance is monitored, and what happens when a tool fails.
Standing or project-based advisory for hospital, health system, and health company boards. AI inventory and risk review, governance structure design, board education, and preparation for certification or regulatory inquiry.
Half-day and full-day working sessions with the C-suite and clinical leadership. Built around your own AI portfolio rather than generic slides. Participants leave with a decision list, not a summary.
Conference keynotes, association annual meetings, and society programs on healthcare AI, clinical judgment, governance, and the future of medicine. Delivered in English or Spanish.
Clinical validity review, go-to-market positioning for provider audiences, advisory board seats, and diligence support for healthcare AI products.
I still practice. I am a board-certified emergency physician. The failure modes I describe are ones I have worked through on a shift, not read about in a case study.
I cite the evidence on the record. Journal, author, year. When I tell a board that a widely deployed sepsis model showed an area under the curve of 0.63 and missed 67 percent of cases in external validation, that is Wong A, Otles E, Donnelly JP, et al., JAMA Internal Medicine, 2021, per PubMed (DOI). You can check me.
I have sat on the regulatory side. I serve on Singapore's Ministry of Health Regulatory Advisory Panel and advise the Texas Medical Association's Committee on Health Information Technology, which represents more than 55,000 Texas physicians.
I have built systems, not only critiqued them. I serve as Chief AI Officer at Phantom Space, where the tolerance for unvalidated systems is even lower than in medicine.
I will tell you when the answer is no. Including when the answer is that you do not need me.
One call. Twenty to thirty minutes. You describe the situation, I tell you whether I am the right person for it.
A scoped proposal. What I would do, over what period, and what you would have at the end.
The work. Board session, retreat, review, or advisory engagement.
If a keynote is a better fit than advisory, or advisory better than a keynote, I will say so on the first call.
What does a healthcare AI board advisor actually do? Helps a board answer four questions with evidence: what AI is running in the organization, who is accountable for each tool, how performance is monitored after go-live, and what the process is for shutting something off. That work includes inventory and risk review, governance design, director education, and preparation for regulatory or certification requirements.
How is this different from hiring a consulting firm? A firm delivers a report produced by a team. This is direct advisory from a practicing physician who will be in the room, will name what is not working, and will not staff the engagement with someone else.
Do you work with organizations outside the United States? Yes. I have advised at ministry level internationally and speak regularly to audiences across Asia, Europe, Australia, and Latin America. Sessions are available in English and Spanish.
Do you serve on boards? Selectively, where the fit is right and the time commitment is realistic. Start with a conversation.
Can you speak in Spanish? Yes. I am a native Spanish speaker and present regularly for Latin American and bilingual audiences.
Do you work with vendors and health technology companies? Yes, on clinical validity, provider-facing positioning, and advisory roles. I do not endorse products in keynotes, and I disclose any relevant relationship before speaking to a provider audience.
What is the fee? It depends on format, travel, and scope. Tell me the date and the ask and I will give you a number on the first call.
How far in advance should we book? Keynote dates are typically set six to twelve months out. Board and advisory work can often start within weeks.
For your board, leadership retreat, or healthcare AI event.
Contact | www.HarveyCastroMD.com | /HarveyCastroMD | #DRGPT
Also represented by Executive Speakers Bureau and BigSpeak.
More from DR GPT™: who DR GPT™ is, speaking, healthcare AI keynotes, books, media kit, and the DR GPT™ Healthcare AI Playbook.
Book Harvey Castro, MD, MBA, known as DR GPT™, for a healthcare AI keynote, board retreat, or executive session.Start the conversation.